Education
About Us
Working with TipRanks
Follow Us
Theralase Technologies (TSE:TLT)
:TLT
TLT Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.14 - C$0.38
Previous CloseN/A
Volume127.37K
Average Volume (3M)91.15K
Market Cap
C$69.38M
Enterprise ValueC$39.87M
Total Cash (Recent Filing)C$114.41K
Total Debt (Recent Filing)C$364.23K
Price to Earnings (P/E)―
Beta0.16
Next Earnings
Apr 23, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding247,780,360
10 Day Avg. Volume87,999
30 Day Avg. Volume91,152
Standard Deviation0.19
R-Squared0.08
Alpha0.00879
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)122.67
Price to Cash Flow (P/CF)-12.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Theralase Technologies News
PremiumCompany Announcements
Theralase’s Rutherrin Shows Promise in Non-Hodgkin’s Lymphoma Treatment
PremiumCompany Announcements
Theralase Validates Effective Treatment for Herpes Virus
PremiumCompany Announcements
Theralase’s Ruvidar Proves Superior to Acyclovir in HSV Treatment
PremiumCompany Announcements
Theralase Expands US Bladder Cancer Study Sites
PremiumCompany Announcements
Theralase Expands Clinical Trial for Bladder Cancer
PremiumCompany Announcements
Theralase Expands Cancer Study with Promising Results
PremiumCompany Announcements
Theralase Reports Revenue Drop Amid Financial Struggles---
Options Prices
Currently, No data available
---
Ownership Overview
TLT FAQ
What was Theralase Technologies’s price range in the past 12 months?
Theralase Technologies lowest stock price was C$0.14 and its highest was C$0.38 in the past 12 months.
What is Theralase Technologies’s market cap?
Theralase Technologies’s market cap is C$69.38M.
When is Theralase Technologies’s upcoming earnings report date?
Theralase Technologies’s upcoming earnings report date is Apr 23, 2025 which is in 55 days.
How were Theralase Technologies’s earnings last quarter?
Theralase Technologies released its earnings results on Nov 27, 2024. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of -C$0.003 by -C$0.001.
Is Theralase Technologies overvalued?
According to Wall Street analysts Theralase Technologies’s price is currently Overvalued.
Does Theralase Technologies pay dividends?
Theralase Technologies does not currently pay dividends.
What is Theralase Technologies’s EPS estimate?
Theralase Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralase Technologies have?
Theralase Technologies has 247,780,360 shares outstanding.
What happened to Theralase Technologies’s price movement after its last earnings report?
Theralase Technologies reported an EPS of -C$0.004 in its last earnings report, missing expectations of -C$0.003. Following the earnings report the stock price went down -30%.
Which hedge fund is a major shareholder of Theralase Technologies?
Currently, no hedge funds are holding shares in TSE:TLT
---
Theralase Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.39%
12-Months-Change
Fundamentals
Return on Equity
-229.60%
Trailing 12-Months
Asset Growth
7.40%
Trailing 12-Months
Company Description
Theralase Technologies
Theralase Technologies Inc is focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications. The company operates in two divisions: The Photo Dynamic Therapy(PDT) division which is into research and development of Photo Dynamic Compounds for the treatment of cancer and Medical Laser Technology(MLT) division which manufactures products used by healthcare practitioners predominantly for the healing of pain. All of the company revenues were generated from MLT division. The company's products include TLC-1000 Controller, TLC-900 Multiple Probe, TLC-300 Triple Probe, and others.
---
TLT Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---